6 Articles
6 Articles
US tariffs pose threat to India's pharma sector
The tariffs proposed by the United States on generic medicines, featuring a 200 percent duty by 2029, not only represent a medium-term risk to India's $9.7 billion pharmaceutical export market but also hurt US patients, analysts said.
·Beijing, China
Read Full Article
Donald Trump's new trade offensive on the pharmaceutical sector is generating strong apprehension in the generic drug industry. The proposal to impose 100% tariffs from 2028 and 200% in 2029 on imports of these drugs raises doubts about its real effects: instead of lowering prices, it may compromise supply and directly penalize American patients. In the United States, generic drugs account for about 90% of prescriptions, but only 13% of total dr…
·Lisboa, Portugal
Read Full ArticleCoverage Details
Total News Sources6
Leaning Left1Leaning Right1Center4Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 17%
C 67%
R 16%
Factuality
To view factuality data please Upgrade to Premium
